After five years behind bars for insider trading, Waksal has announced another biotech deal: His new drug company Kadmon Pharmaceuticals has bought privately held Three Rivers Pharmaceuticals in a private deal estimated at over…
GlaxoSmithKline Plc agreed to pay $750 million to settle charges that the drug making giant sold contaminated anti-nausea medication and baby ointment made at a now-closed Cidra plant in Puerto Rico.
Continue r…
Bristol-Myers Squibb, which sells blood thinner Plavix, today reported better-than-expected third quarter earnings, mainly due to cost cuts. Revenue, however, fell short of expectations, and shares are down in trading Tuesday.
…
Drugstore chain Walgreen is looking to sell its pharmacy-benefits management business and has hired Bank of America to run an auction.
Continue reading Walgreen Seeks to Sell Pharmacy-Benefits Business
…
DuPont (DD) reported third-quarter earnings of 40 cents per share, down from 45 cents per share a year earlier.
Sales grew 17% from a year earlier to $7 billion, the company said in a statement. Sales grew 22% in emerging markets.
The company saw a decline of 13 cents per share in pharmaceuticals income related to patent expirations.
“I am proud of our business teams’ performance…
Continue reading DuPont Earnings Drop, but Raises Outlook
DuPont Earnings Drop, but Raises Outlook originally appeared on DailyFinance on Tue, 26 Oct 2010 06:40:00.
Filed Under: Company News, Health Care, Earnings, Retail, DuPont